Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
a Serum E2 levels in male healthy controls vs. male dcSSc patients. The ...
Ultrasound findings of the dcSSc patients and the control's right ...
Kaplan-Meier survival analysis dcSSc patients. dcSSc = diffuse ...
Use of immunosuppressive agents in systemic sclerosis subtypes. dcSSc ...
Expression levels of survivin and its variants in total-SSc, DcSSc ...
Demographic and clinical features of systemic sclerosis patients dcSSc ...
Revised CRISS Developed to Improve dcSSc Study Outcome Measures in ...
New skin markers help doctors refine dcSSc treatment prognosis ...
Consensus recommendations for SSc-ILD treatment criteria. dcSSc diffuse ...
Clinical and laboratory characteristics of patients with dcSSc ...
Diffuse Cutaneous Systemic Sclerosis Market Outlook | dcSSc Market Report
Q&A: Study of Lenabasum in dcSSc Shows Immunosuppressive Therapy ...
A 62-year-old female patient with dcSSc showed a green pattern on ...
The clinical characteristics of lcSSc compared with dcSSc patients with ...
Cytokine profile supernatants from juvenile dcSSc and LS PBMC ...
| Proteomic analysis revealed that dcSSc ATA+ purified IgG induced ...
Systemic sclerosis. A complex multisystem disease | Medicine Today
Overview of Scleroderma | PPT
FRI0270 Patient Perception of Disease Burden in Diffuse Cutaneous ...
Systemic sclerosis
Diffuse cutaneous systemic sclerosis (dcSSc) skin,... | Download ...
Systemic sclerosis sine scleroderma: clinical and serological features ...
Lenabasum is new treatment for diffuse cutaneous systemic sclerosis (dcSSc)
PPT - Systemic Sclerosis (Scleroderma) PowerPoint Presentation, free ...
Diffuse cutaneous systemic sclerosis (dcSSc) skin, transmission ...
Immunoglobulins G from Systemic Sclerosis Patients May Alter the ...
Changes of Cerebral Structure and Perfusion Vary in Different Subtypes ...
Single-cell analysis reveals key differences between early-stage and ...
Methodology employed to evaluate the impact of dcSSc. No ethnography ...
Systemic sclerosis: clinical features and management - Medicine
Systemic sclerosis | PPT
Diffuse Cutaneous Systemic Sclerosis – Life Clinical Trials
Systemic sclerosis in adults. Part I: Clinical features and ...
Survival and prognosis factors in systemic sclerosis: data of a French ...
Single-cell transcriptome analysis identifies skin-specific T-cell ...
Diffuse Cutaneous Systemic Sclerosis (dcSSc) - Multiple Locations in ...
Comparisons of serum IL-33 level. SSc, systemic sclerosis; lcSSc ...
Use of corticosteroids in systemic sclerosis subtypes. dcSSc, diffuse ...
Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Abbreviations dcSSc: Diffuse cutaneous systemic sclerosis; EBV ...
Use of different immunosuppressive agents in systemic sclerosis ...
The Pathogenesis of Systemic Sclerosis: An Understanding Based on a ...
Clinical risk assessment of organ manifestations in systemic sclerosis ...
Full article: The role of regional and neuroaxial anesthesia in ...
Engaging the PD-1 Pathway Attenuates Inflammation Associated Fibrosis ...
New insight on the Xq28 association with systemic sclerosis - Annals of ...
Abbreviations dcSSc: Diffuse systemic sclerosis; ILD: Interstitial lung ...
The burden of systemic sclerosis in Switzerland – the Swiss systemic ...
Frontiers | Pathogenesis of Systemic Sclerosis
Frontiers | Metabolic fingerprinting of systemic sclerosis: a ...
Systemic Sclerosis and Sclerodermoid Disorders - Clinical Tree
Systemic Sclerosis Skin Disease Research | PPTX
Metabolic pathway analysis of diffuse cutaneous (dcSSc) and limited ...
Scleroderma Overview & Insights | PPTX
Skin Macrophage Subtypes and Impact of Tofacitinib in Early Diffuse ...
(PDF) Patient perception of disease burden in diffuse cutaneous ...
Hand Impairment in Systemic Sclerosis: Various Manifestations and ...
Patient perception of disease burden in diffuse cutaneous systemic ...
The Preventive Role of Physical Activity in Systemic Sclerosis: A Cross ...
SSc-associated myopathy: clinical, immunological, and pathological ...
systemic sclerosis and scleroderma powerpoint | PPTX
Systemic Sclerosis (SSc) Review | Rheumatology | EMJ Reviews
Overlap syndromes in systemic sclerosis - PMC
Clinical and pathologic outcomes in patients with diffuse cutaneous ...
PPT - EliA Fibrillarin PowerPoint Presentation, free download - ID:1079297
Systemic sclerosis - The Lancet
Systemic Sclerosis and Sclerodermoid Disorders | Plastic Surgery Key
SSc-ILD (ILD related to Scleroderma) | OFEV® (nintedanib)
Systemic Sclerosis
Consensus recommendations for screening criteria for SSc-ILD. *Data ...
Disease progression in systemic sclerosis-overlap syndrome is ...
Skin Signs of Systemic Disease - Clinical GateClinical Gate
Optimal Combination of Circulating Biomarkers for Predicting the ...
How Systemic Sclerosis affects the Skin - A/Prof Amanda Saracino ...
Approach to pre-treatment evaluation in patients with SSc. (A) Disease ...
The Evolving Landscape of Systemic Sclerosis Pathogenesis: From ...
40 years-old male SSc patient (dcSSc pattern) with 13-years history of ...
Serum concentration of copeptin in control group, patients with ...
Anti-Topoisomerase Antibody in dcSSc: Unravelling Its Intracellular ...
Disturbed Complement Receptor Expression Pattern of B Cells Is Enhanced ...
Scleroderma - Myositis Support and Understanding
Progressive Skin Fibrosis in SSc Associated With Lung Function Decline ...
Effect of Anabasum (JBT-101) on Gene Expression in Skin Biopsies from ...
Current Approaches to the Management of Early Active Diffuse ...
Stamceltransplantatie reduceert B-celactiviteit bij patiënten met ...
Integrated Molecular Analysis of Systemic Sclerosis Skin and Blood ...
Characteristics of the patients studied. Diffuse cutaneous SSc (dcSSc ...
Functional analysis of miR-21 in dcSSc, TGF-b-treated, and normal ...
(PDF) OP0250 EFFICACY and Safety of Romilkimab in Diffuse Cutaneous ...
Strategy for treatment of fibrosis in systemic sclerosis: Present and ...
Frontiers | Human leukocyte antigen association in systemic sclerosis ...
Table 1 from Vascular involvement in systemic sclerosis (scleroderma ...
Risk Factors for Progression of Interstitial Lung Disease in Patients ...
Senescent Cells Accumulate in Systemic Sclerosis Skin - Journal of ...
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of ...
(PDF) AN LPAR1 ANTAGONIST, IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Diffuse cutaneous systemic sclerosis (dcSSc) - Market Insights ...
30933-9%2Fasset%2F2af0bf8a-1a9e-42ce-af96-99c5919397b8%2Fmain.assets%2Fgr1_lrg.jpg&w=3840&q=75)
